Search Results - "Vora, S.A."

Analysis of Magnetic Resonance Imaging Volumetric Changes Following Hypofractionated Stereotactic Radiation Therapy for Benign Intracranial Neoplasms by Fega, R, Fletcher, G.P, Peterson, J.L, Waddle, M.R, Barrs, D.M, Ashman, J.B, Bendok, B.R, Patel, N.P, Vora, S.A

Get full text

Patients With Oligometastatic Disease Limited to the Chest Are Optimal Candidates for Lung Stereotactic Body Radiation Therapy by Fega, R, Goyal, U, Ross, H, Jaroszewski, D, Paripati, H, Kosiorek, H, Daniels, T.B, Schild, S.E, Rule, W.G, Vora, S.A, Ashman, J.B

Get full text

Five-year Outcome of a Prospective Study Evaluating Hypofractionated Whole Breast External Beam Irradiation and Tumor Bed Boost with Intra-operative Electron Irradiation (IOERT) For T1/T2 N0 Breast Cancer by Wong, W.W, Pockaj, B.A, Vora, S.A, Halyard, M.Y, Gray, R.J, Schild, S.E

Get full text

Five-year Outcome of a Prospective Study Evaluating Tumor Bed Boost with Intra-operative Electron Irradiation (IOERT) in Breast Conserving Treatment for T1/T2 N0 Breast Cancer by Wong, W.W, Pockaj, B.A, Vora, S.A, Halyard, M.Y, Gray, R.J, Schild, S.E

Get full text

Analysis of Biochemical Control, Prognostic Factors and Toxicities in Patients Treated with Intensity Modulated Radiotherapy for Localized Prostate Cancer with Longer Follow-up by Vora, S.A, Wong, W.W, Schild, S.E, Ezzell, G.A

Get full text

Comparison of the Outcomes of Various Radiation Treatment Modalities for Prostate Cancer by Wong, W.W, Schild, S.E, Vora, S.A, Ezzell, G.A

Get full text

Intensity Modulated Radiation Therapy (IMRT) for Prostate Cancer: Phase I/II Study of Concomitant Boost using Indium in 111 Capromab Pendetide (Prostascint) Imaging by Wong, W.W, Schild, S.E, Vora, S.A, Roarke, M.C, Nguyen, B.D, Ram, P.C, Ezzell, G.A

Get full text

Dosimetric Comparison between Photon and Proton Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations: A Single Institution Experience by Sperduto, W., Flakus, M.J., Vora, S.A., Clouser, E.L., Bendok, B.R., Lara, P.R., Stefan, C.A., Bues, M.

“…Stereotactic radiosurgery (SRS) is a well-established treatment for inoperable cerebral arteriovenous malformations (AVMs). Months to years following SRS,…”
Get full text

Robust Optimization for Spot Scanning Proton Therapy Based on Dose-Linear Energy Transfer (LET) Volume Constraints by Chen, J., Yang, Y., Feng, H., Vargas, C.E., Yu, N.Y., Rwigema, J.C., Keole, S.R., Vora, S.A., Shen, J., Liu, W.

“…Historically, spot scanning proton therapy (SSPT) treatment planning utilizes dose volume constraints and linear-energy-transfer (LET) volume constraints…”
Get full text

Patient-Specific 3D CT Images Reconstruction from 2D KV Images Via Vision Transformer-Based Deep-Learning by Ding, Y., Holmes, J., Li, B., Vargas, C.E., Vora, S.A., Wong, W.W., Fatyga, M., Foote, R.L., Patel, S.H., Liu, W.

“…In some proton therapy facilities, patient alignment relies on two 2D orthogonal kV images, taken at fixed, oblique angles, as no 3D on-the-bed-imaging is…”
Get full text

Predictors of Clinically Significant Change on the Brief Fatigue Inventory by Gunn, H.J., Cameron, J.D., Mahajan, A., Brown, P.D., Yan, E.S., Vora, S.A., Merrell, K.W., Stafford, S.L., Ashman, J.B., Peterson, J.L., Leenstra, J.L., Wilson, Z., Laack, N.N., Breen, W.

“…Patients with brain tumors often experience fatigue after treatment that impacts their quality of life (QOL). Patient-reported outcomes (PROs) including the…”
Get full text

Development of an Automated Simulation-Free Platform for Emergent Radiotherapy by Tegtmeier, R.C., Clouser, E.L., Labbe, A., Jr, J.S. Aguilar, Rule, W.G., Vora, S.A., Ahmed, S.K., Buckey, C.R., Chungbin, S.J., Yan, J., Chen, Q., Rong, Y.

“…Palliative radiotherapy (RT) for oncologic emergencies poses distinct patient safety challenges due to limited access to standard clinical resources beyond…”
Get full text

Fine-Tuning Large Language Models for Radiation Oncology, A Specialized Health Care Domain by Wang, P., Liu, Z., Li, Y., Holmes, J., Shu, P., Zhang, L., Li, X., Li, Q., Vora, S.A., Patel, S.H., Sio, T.T.W., Liu, T., Liu, W.

“…To answer the question of whether fine-tuned large language models (LLM) perform better than vanilla LLMs on radiation oncology clinical tasks and to compare…”
Get full text

Advanced Solution: Accurate Patient Alignment without Unnecessary Imaging Dose via Synthesizing Patient-Specific 3D CT Images from 2D KV Images by Ding, Y., Holmes, J., Feng, H., Li, B., McGee, L.A., Rwigema, J.C., Vora, S.A., Wong, W.W., Ma, D.J., Foote, R.L., Patel, S.H., Liu, W.

“…In radiotherapy, image-guided patient alignment is essential for accurate treatment plan delivery. When 3D on-board imaging (OBI) is unavailable, two 2D…”
Get full text

Patient-specific 3D CT Images Reconstruction from 2D KV Images by Ding, Y., Patel, S.H., Holmes, J., Feng, H., McGee, L.A., Rwigema, J.C., Vora, S.A., Wong, W.W., Ma, D.J., Foote, R.L., Li, B., Liu, W.

“…In some proton therapy facilities, patient alignment relies on two 2D orthogonal kV images, taken at fixed, oblique angles, as no 3D on-the-board-imaging is…”
Get full text

Tumor Treating Fields Utilization for Glioblastoma at a Large Multicenter Academic Practice by Crompton, D.J., Kern, S., Burns, T., Jaeckle, K., Brown, P.D., Quinones-Jinojosa, A., Laack, N.N., Bogan, A.W., Uhm, J.H., Ruff, M., Do, B., Sener, U., Peterson, J.L., Vora, S.A., Breen, W., Trifiletti, D.M.

“…Glioblastoma (GBM) is the most aggressive primary brain tumor, with inevitable recurrence despite trimodality therapy. Tumor Treating Fields (TTF) are included…”
Get full text

Advanced MRI and 18F-DOPA PET/CT and Their Impact on Radiotherapy Target Volumes in Glioblastoma by Younus, E., Qian, J., Pafundi, D.H., Johnson, D.R., Chitsazzadeh, S., Kaufmann, T., Trifiletti, D.M., Peterson, J.L., Kim, M.M., Vora, S.A., Sener, U., Ruff, M., Brown, P.D., Sarkaria, J.N., Mahajan, A., Yan, E.S., Laack, N.N., Kowalchuk, R.O., Brinkmann, D.H., Breen, W.

“…Although gadolinium contrast-enhanced MRI is standardly used to identify the gross tumor volume (GTV) during target delineation for radiotherapy for…”
Get full text

Modern Patterns of Failure for Glioblastoma at a Large Multicenter Academic Practice by Crompton, D.J., Kern, S., Bogan, A.W., Do, B., Vora, S.A., Quinones-Jinojosa, A., Burns, T., Jaeckle, K., Brown, P.D., Laack, N.N., Peterson, J.L., Uhm, J.H., Ruff, M., Sener, U., Breen, W., Trifiletti, D.M.

“…Glioblastoma (GBM) is the most aggressive primary brain tumor, with inevitable recurrence despite trimodality therapy, and an overall survival of approximately…”
Get full text

Late Gastrointestinal and Genitourinary Toxicities of a Moderately Hypofractionated Regimen of Intensity-Modulated Proton Therapy Targeting the Prostate/Seminal Vesicles and Pelvic Lymph Nodes for High Risk or Unfavorable Intermediate Risk Prostate Cancer by Choo, C.R., Hillman, D., Mitchell, C., Daniels, T.B., Vargas, C., Rwigema, J.C., Corbin, K.S., Keole, S.R., Vora, S.A., Merrell, K.W., Stish, B.J., Pisansky, T.M., Davis, B.J., Wong, W.W.

Get full text

Can Modeling of Acute Rectal Toxicity in IMRT Treatments for Prostate Cancer be Used for Quality Assurance? by Fatyga, M., Schild, S.E., Schild, M., Vora, S.A., Wong, W.W., Herman, M.G., Liu, X., Li, J.

Get full text